EVIDENCE OF DONOR‐SPECIFIC CELLULAR SUPPRESSOR ACTIVITY IN DONOR‐SPECIFIC CELL‐MEDIATED LYMPHOLYSIS UNRESPONSIVENESS IN RENAL TRANSPLANT PATIENTS

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Transplantation

• Publication date

  1987-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-198709000-00013PMID 2957836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppressor cells in antithymocyte globulin-induced transplantation tolerance in the adult rat.

  1984cited by this paper
• SUPPRESSOR CELLS AND THEIR ROLE IN THE SURVIVAL OF IMMUNOLOGICALLY ENHANCED RAT KIDNEY ALLOGRAFTS

  1984cited by this paper
• Enforcement of specific unresponsiveness by the long-term presence of allogeneic heart grafts.

  1984cited by this paper
• CELL‐MEDIATED CYTOTOXICITY TOWARD THE DONOR IN PATIENTS WITH WELL‐FUNCTIONING KIDNEY GRAFTS: POSSIBLE MECHANISM OF SPECIFICALLY REDUCED CYTOTOXIC RESPONSE

  1983cited by this paper
• DONOR‐SPECIFIC DECREASED CELL‐MEDIATED CYTOTOXICITY IN RECIPIENTS OF WELL FUNCTIONING, ONE HLA HAPLOTYPE‐MISMATCHED KIDNEY ALLOGRAFTS

  1983cited by this paper
• In vivo induction of specific suppressor lymphocytes to histocompatibility antigens.

  1981cited by this paper
• INDUCTION OF SUPPRESSOR CELLS BY DONOR‐SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATS

  1981cited by this paper
• CELL‐MEDIATED LYMPHOLYSIS STUDIES IN RENAL ALLOGRAFT RECIPIENTS

  1981cited by this paper
• Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.

  1980cited by this paper
• Induction of suppressor cells and allograft tolerance.

  1980cited by this paper
• Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.

  1979cited by this paper
• Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.

  1978cited by this paper

• MÉTODOS NÃO INVASIVOS DE AVALIAÇÃO DO RISCO DE REJEIÇÃO DO ENXERTO RENAL

  2011cites this paper
• Noninvasive methods to assess the risk of kidney transplant rejection

  2009cites this paper
• Beyond histology: novel tools to diagnose allograft dysfunction.

  2006cites this paper
• Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe.

  2005cites this paper
• Donor specific hyporesponsiveness in renal transplant recipients

  2005cites this paper
• Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients

  2004cites this paper
• Detection of regulatory cells as an assay for allograft tolerance in miniature swine.

  2004cites this paper
• Donor specific antibody suppression in ABO incompatible kidney transplantation.

  2001cites this paper
• Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.

  2000cites this paper
• [The mechanism of donor specific unresponsiveness in renal transplant recipients].

  1998cites this paper
• Sequential mixed lymphocyte culture after kidney transplantation: induction of tolerance or sensitization.

  1997cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Rejection of discordant neovascularized xenografts: is it similar to the response against metazoan parasites?

  1996cites this paper
• Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world.

  1996cites this paper
• A new method to detect response of lymphocytes to allo-antigens.

  1996cites this paper
• A New Method to Detect Response of Lymphocytes to Alla-antigens

  1996cites this paper
• A sanguine outlook: The role of donor-specific transfusion in renal transplantation and tolerance

  1995cites this paper
• Allogeneic microchimerism and donor antigen‐specific hyporeactivity in lung transplant recipients

  1995cites this paper
• Cell surface phenotype and in vitro donor antigen-specific hyporesponsiveness in recipients of living donor kidney transplants.

  1995cites this paper
• Posttransplant donor antigen-specific hyporeactivity in human transplantation

  1995cites this paper
• Inhibition of IL‐2 synthesis by donor‐pecific suppressor T cells in a renal transplant recipient

  1994cites this paper
• Donor-specific suppressor T cells in a renal transplant recipient with a well-functioning kidney.

  1994cites this paper
• A POSSIBLE ROLE FOR SPECIFIC “ANERGY” IN IMMUNOLOGIC HYPOREACTIVITY TO DONOR STIMULATION IN HUMAN KIDNEY ALLOGRAFT RECIPIENTS1

  1993cites this paper
• Cell‐Mediated Immune Responses in Renal Transplant Recipients treated with Cyclosporin and Prednisolone with or without Azathioprine

  1993cites this paper
• Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum?

  1993cites this paper
• EVIDENCE THAT IMPROVED LATE RENAL TRANSPLANT OUTCOME CORRELATES WITH THE DEVELOPMENT OF IN VITRO DONOR ANTIGEN‐SPECIFIC HYPOREACTIVITY

  1993cites this paper
• The goal of specific immunologic unresponsiveness in clinical kidney transplantation.

  1992cites this paper
• Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis.

  1990cites this paper
• A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.

  1990cites this paper
• Development of a tolerogenic immune balance and elimination of autoreactive B cells--two important effects of antithymocyte globulin treatment.

  1990cites this paper
• Characterization of cloned human suppressor T cells generated from one-way MLC.

  1989cites this paper
• Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value.

  1989cites this paper